Patent ID: 7294687
Filing Date: 2007-11-13
Classification: A61K,A61P,B82Y

Abstract:
1. A pharmaceutical composition comprising an aqueous carrier; from 0.1 mg/ml to 2.5mg/ml of the composition of an acetate salt of a peptide having the structural formula from 70 mg/ml to 170 mg/ml of the composition of hepta-(sulfobutyl ether)-β-cyclodextrin or a salt of hepta-(sulfobutyl ether)-β-cyclodextrin, wherein the peptide and the hepta-(sulfobutyl ether)-β-cyclodextrin or a salt of hepta-(sulfobutyl ether)-β-cyclodextrin are dissolved in the aqueous carrier; and wherein the pharmaceutical composition has a pH between 6.5 and 8.5.